The medication is available via retail pharmacies and institutions, including hospitals, and is the second generic of Narcan by a New Jersey pharmaceutical company announced last week. Teva Pharmaceuticals also launched a generic of Narcan.
According to the Centers for Disease Control and Prevention, someone dies in the United States every eight minutes from an opioid overdose. The National Institute on Drug Abuse Opioid reported that opioid overdose related deaths have been continuously increasing in the U.S. for over two decades.
“Now more than ever, it’s imperative that Americans have increased access to life-saving opioid overdose reversal medicines for themselves or a loved one,” said Sandoz President Keren Haruvi in a prepared statement. “The launch of our authorized generic of Narcan Nasal Spray reinforces our commitment to delivering high-quality, affordable generic medicines and to do our part to help address the public health epidemic for people at risk for opioid overdose.”
More than one-third of the 49 million patients prescribed opioids in the U.S. are considered at-risk, but only 5% have a prescription for naloxone, according to the IQVIA Pharmacy Claims Database.[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row]